Compound Detail
CHEMBL4847944
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4847944 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FNDMRQJQVHEQAH-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
198.3
MW (Da)
3.62
ALogP
2
HBA
0
HBD
18.5
PSA (Ų)
0.35
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 7.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Plasmodium falciparum CHEMBL364 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
| Candida albicans CHEMBL366 | IC50 | 4.6 | 4.6 | 25240.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Plasmodium falciparum | IC50 | = | 100.0 | nM | 7.0 | Antimalarial activity against Plasmodium falciparum 3D7 assessed as inhibition o... | 34116159 |
| Candida albicans | IC50 | = | 25240.0 | nM | 4.6 | Antifungal activity against Candida albicans CAAL93 assessed as reduction in fun... | 34116159 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34116159 | 10.1016/j.bmcl.2021.128196 | Leishmania donovani | 2 |
| 34116159 | 10.1016/j.bmcl.2021.128196 | ADMET | 2 |
| 34116159 | 10.1016/j.bmcl.2021.128196 | Candida albicans | 1 |
| 34116159 | 10.1016/j.bmcl.2021.128196 | Aspergillus fumigatus | 1 |
| 34116159 | 10.1016/j.bmcl.2021.128196 | Plasmodium falciparum | 1 |
| 34116159 | 10.1016/j.bmcl.2021.128196 | HUVEC | 1 |
Data from ChEMBL 36 via Core Engine